Specialised in health insurance, Religare unlisted shares prices have recently increased amidst its completion of a one-time-settlement (OTS) by the subsidiary. This has created a buzz among investors in the grey market to invest in its unlisted shares. The company has been performing well since its inception and has exceeded 7x income in the last five years. The company’s net income surged from Rs. 322.9 crores to Rs. 341.4 crores in FY 22-23.
Talking about the IPO journey, the company is planning to release its IPO worth Rs. 2,000 crores, which has given investors a positive outlook to buy Religare unlisted stocks. If you want to diversify your investment portfolio, Religare unlisted shares should be your go-to option. However, it is important to discuss the financial reports of the company for FY 22-23 before making investment decisions. So, let’s get started below.
Overview Of Religare Financial Performance For FY 22-23
In FY 21-22, the company’s Gross Written Premium was Rs. 3,947.44 crores, Net Written Premium was Rs. 3,088.42 crores, profit before tax (PAT) was Rs. 15.55 crores and profit after tax (PAT) was Rs. 11.50 crores. But how much the company earned in FY22-23 is the question here. We have listed the company’s financials based on months below for you to understand. Have a look at them below.
1 April – 30 June 2022
In the first quarter of FY 22-23, the company registered revenue from operations of Rs. 439.64 crores. This includes the interest income, which was Rs. 243.01 crores, and income from insurance premiums was Rs. 196.63 crores. Further, the other income was Rs. 208.45 crores, which made total revenue Rs. 648.09 crores.
1 July – 30 September 2022
In the second quarter of FY 22-23, the company’s performance was high as its tidal revenue from operations was Rs. 730.15 crores. The interest income was recorded at Rs. 684.12 crores, while income from insurance premiums was Rs. 46.03 crores, which led to a total revenue of Rs. 1096.33 crores. This is quite a high revenue compared to the first quarter.
1 October – 31 December 2022
The company’s performance was a little down in the third quarter due to low business operations. So, the interest income they registered was Rs. 584.59 crores, net gain on fair value changes was Rs. 2.30 crores, and other revenue from operations was Rs. 7.11 crores. Also, the additional income includes Rs. 261.71 crore, which led to the company’s Rs. 855.71 crore total revenue.
1 January – 31 March 2023
The last quarter of FY 22-23, or the beginning of the new year, was fortunate for Religare Health Insurance. Yes, because the company registered a total revenue of Rs. 4,082.90 crore, which includes interest income of Rs. 531.02 crore, income from insurance premiums of Rs. 5.88 crore, and other income of Rs. 3,546.00 crore.
Overall, if you see Religare Health Insurance’s financial performance for FY22-23 was positive. Out of four, in the three quarters, the company performed well financially and registered high revenue from its operations. This gives investors confidence in buying Religare unlisted shares without a second thought.
Future Of Religare Unlisted Shares
Undoubtedly, the future of Religare Health Insurance seems to be positive after analysing its financial performance for FY 22-23. Also, as the company gears up to launch its IPO worth Rs. 2000 crore towards the end of the current financial year, it shows that they are looking to expand their business operations and presence tremendously. Currently, the company offers products in the retail segments, including critical illness, personal accident, health insurance, international travel insurance, top-up coverage, group health insurance, group personal accident insurance, etc.
Invest With Stockify
Currently, Religare unlisted shares are available for trading at Rs. 179 per equity share. As a potential investor, if you’re planning to expand your investment portfolio and earn high revenue, early investment in Religare pre-IPO shares could be a golden opportunity for you. You can diversify your risk and be a part of the company’s growth by investing in its unlisted shares.
If you’re looking for the best online stock broking platform in India, Stockify is here to help. We have a team of certified and experienced expert brokers who can guide you through the buying and selling of unlisted shares. Connect with our expert brokers and start trading in the unlisted world seamlessly.
FAQs
Why should I invest in Religare unlisted shares?
Ans. Religare is a prominent health insurance company that has been performing well since its inception. The company has surpassed 7x income in the past five years, and its net income increased to Rs. 341.4 crores in FY 22-23 against Rs. 322.9 Crores in FY 21-22.
How do I buy Religare unlisted shares?
Ans. You can buy Religare pre-IPO stocks at Stockify. We have a team of expert brokers who can help you buy and sell unlisted stocks of top pre-IPO companies in India.
What is the Religare unlisted shares price today?
Ans. Currently, Religare unlisted shares are trading at Rs. 188. However, the prices keep fluctuating depending on the market trends and the company’s performance.
What information should I look for while buying Religare pre-IPO stocks?
Ans. Before buying Religare unlisted stocks, you must check for EBITDA, EPS Growth, Profit and Loss statement, revenue of the company, etc. Expert brokers will provide you with every necessary information you want.
Which is the best online trading platform in India?
Ans. Stockify is regarded as the best online trading platform in India, where we help potential investors buy and sell unlisted stocks of top pre-IPO companies in India. Let’s connect today.
